Allergan (AGN) Tops Q2 EPS by 1c

Allergan (NYSE: AGN) reported Q2 EPS of $3.35, $0.01 better than the analyst estimate of $3.34. Revenue for the quarter came in at $3.68 billion versus the consensus estimate of $4.1 billion.

For earnings history and earnings-related data on Allergan (AGN) click here.

You May Also Be Interested In

• Activist investor presses Xerox to review financial services arm - Bloomberg
• Canaan Inc. (CAN) PT Lowered to $2 at BTIG
• Barnes & Noble Education (BNED) Tops Q1 EPS by 12c